Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP738839.RATdfeYPH8gnSlPKh66RDL3x5H9L_jmkTFGkTFJiQNrHQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP738839.RATdfeYPH8gnSlPKh66RDL3x5H9L_jmkTFGkTFJiQNrHQ130_assertion type Assertion NP738839.RATdfeYPH8gnSlPKh66RDL3x5H9L_jmkTFGkTFJiQNrHQ130_head.
- NP738839.RATdfeYPH8gnSlPKh66RDL3x5H9L_jmkTFGkTFJiQNrHQ130_assertion description "[Preliminary in vitro and in vivo studies with valproic acid (VPA) in cell lines and patients with spinal muscular atrophy (SMA) demonstrate increased expression of SMN, supporting the possibility of therapeutic benefit.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP738839.RATdfeYPH8gnSlPKh66RDL3x5H9L_jmkTFGkTFJiQNrHQ130_provenance.
- NP738839.RATdfeYPH8gnSlPKh66RDL3x5H9L_jmkTFGkTFJiQNrHQ130_assertion evidence source_evidence_literature NP738839.RATdfeYPH8gnSlPKh66RDL3x5H9L_jmkTFGkTFJiQNrHQ130_provenance.
- NP738839.RATdfeYPH8gnSlPKh66RDL3x5H9L_jmkTFGkTFJiQNrHQ130_assertion SIO_000772 19440247 NP738839.RATdfeYPH8gnSlPKh66RDL3x5H9L_jmkTFGkTFJiQNrHQ130_provenance.
- NP738839.RATdfeYPH8gnSlPKh66RDL3x5H9L_jmkTFGkTFJiQNrHQ130_assertion wasDerivedFrom befree-2016 NP738839.RATdfeYPH8gnSlPKh66RDL3x5H9L_jmkTFGkTFJiQNrHQ130_provenance.
- NP738839.RATdfeYPH8gnSlPKh66RDL3x5H9L_jmkTFGkTFJiQNrHQ130_assertion wasGeneratedBy ECO_0000203 NP738839.RATdfeYPH8gnSlPKh66RDL3x5H9L_jmkTFGkTFJiQNrHQ130_provenance.